insulin novo nordisk - Search News

FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic

Novo’s Ozempic Shortage Is Declared Over, Hitting Copycats

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s expected to curtail widespread access to cheaper copies of the popular medications.

NBC New York · 4h

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

Reuters on MSN · 4h

Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail widespread sales of cheaper copies made by compounding pharmacies.

Foes in FTC Insulin-Price Case Fire Off Subpoenas in Every Direction, From McDonald’s to Defense Department

After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of ...

FiercePharma6h

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

Novo Nordisk Prices In Too Few New Patients For GLP-1 Currently

Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic

Trending now